Wunai Zhang

809 total citations · 1 hit paper
15 papers, 611 citations indexed

About

Wunai Zhang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Wunai Zhang has authored 15 papers receiving a total of 611 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Wunai Zhang's work include Cancer, Lipids, and Metabolism (2 papers), Ferroptosis and cancer prognosis (2 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Wunai Zhang is often cited by papers focused on Cancer, Lipids, and Metabolism (2 papers), Ferroptosis and cancer prognosis (2 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Wunai Zhang collaborates with scholars based in China and Germany. Wunai Zhang's co-authors include Simei Zhang, Weikun Qian, Zheng Wang, Yangyang Yue, Ying Xiao, Shuai Wu, Tao Qin, Li Li, Weifan Zhang and Zeen Zhu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Letters and Cell Death and Disease.

In The Last Decade

Wunai Zhang

14 papers receiving 607 citations

Hit Papers

NLRP3 Inflammasome and Inflammatory Diseases 2020 2026 2022 2024 2020 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wunai Zhang China 10 348 132 119 109 98 15 611
Xianguo Chen China 17 396 1.1× 105 0.8× 230 1.9× 104 1.0× 89 0.9× 50 769
Hongxiu Han China 13 304 0.9× 101 0.8× 179 1.5× 68 0.6× 129 1.3× 24 630
Minseob Eom South Korea 14 352 1.0× 127 1.0× 121 1.0× 69 0.6× 172 1.8× 45 797
Tao Qin China 14 388 1.1× 50 0.4× 112 0.9× 136 1.2× 166 1.7× 20 702
Linhai Zhu China 14 272 0.8× 138 1.0× 98 0.8× 50 0.5× 183 1.9× 55 605
Ruibao Chen China 14 312 0.9× 82 0.6× 106 0.9× 59 0.5× 50 0.5× 32 609
Longjiang Shao United States 16 405 1.2× 196 1.5× 199 1.7× 103 0.9× 86 0.9× 24 834
Shilei Zhao China 19 447 1.3× 122 0.9× 155 1.3× 76 0.7× 95 1.0× 52 776
Huishan Zhao China 16 328 0.9× 93 0.7× 166 1.4× 160 1.5× 102 1.0× 43 754

Countries citing papers authored by Wunai Zhang

Since Specialization
Citations

This map shows the geographic impact of Wunai Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wunai Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wunai Zhang more than expected).

Fields of papers citing papers by Wunai Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wunai Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wunai Zhang. The network helps show where Wunai Zhang may publish in the future.

Co-authorship network of co-authors of Wunai Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Wunai Zhang. A scholar is included among the top collaborators of Wunai Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wunai Zhang. Wunai Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Zhou, Cancan, Zhengyuan Feng, Weikun Qian, et al.. (2025). Elevated SREBP1 accelerates the initiation and growth of pancreatic cancer by targeting SOX9. Biology Direct. 20(1). 6–6. 1 indexed citations
2.
Wu, Shuai, Jiaqiang Ren, Weikun Qian, et al.. (2023). Synergistic effects of resveratrol with gemcitabine in pancreatic cancer chemotherapy by inhibiting the c-Met/PARP1 axis. SHILAP Revista de lepidopterología. 7(4). 267–278.
3.
Zhang, Weifan, Mengyuan Gong, Wunai Zhang, et al.. (2022). Thiostrepton induces ferroptosis in pancreatic cancer cells through STAT3/GPX4 signalling. Cell Death and Disease. 13(7). 630–630. 122 indexed citations
4.
Zhang, Simei, Shuang Cao, Mengyuan Gong, et al.. (2022). Mechanically activated ion channel Piezo1 contributes to melanoma malignant progression through AKT/mTOR signaling. Cancer Biology & Therapy. 23(1). 336–347. 21 indexed citations
5.
Zhang, Weifan, Weikun Qian, Mengyuan Gong, et al.. (2022). Mutant p53 driven-LINC00857, a protein scaffold between FOXM1 and deubiquitinase OTUB1, promotes the metastasis of pancreatic cancer. Cancer Letters. 552. 215976–215976. 29 indexed citations
6.
Zhang, Wunai, Rui He, Wenbin Yang, et al.. (2022). Autophagic Schwann cells promote perineural invasion mediated by the NGF/ATG7 paracrine pathway in pancreatic cancer. Journal of Experimental & Clinical Cancer Research. 41(1). 63 indexed citations
7.
Yue, Yangyang, Kaijie Wu, Weikun Qian, et al.. (2022). RASAL2 mediated the enhancement of YAP1/TIAM1 signaling promotes malignant phenotypes of pancreatic ductal adenocarcinoma. International Journal of Biological Sciences. 18(10). 4245–4259. 3 indexed citations
8.
Zhu, Zeen, Xueni Wang, Wunai Zhang, et al.. (2022). Huaier suppresses pancreatic cancer progression via activating cell autophagy induced ferroptosis. Frontiers in Oncology. 12. 960858–960858. 16 indexed citations
9.
Zhang, Lun, Wunai Zhang, Xin Zhang, et al.. (2022). High‑glucose microenvironment promotes perineural invasion of pancreatic cancer via activation of hypoxia inducible factor 1α. Oncology Reports. 47(4). 9 indexed citations
10.
Zhang, Weifan, Simei Zhang, Wunai Zhang, et al.. (2021). Matrix stiffness and its influence on pancreatic diseases. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1876(1). 188583–188583. 32 indexed citations
11.
Qin, Tao, Jie Li, Ying Xiao, et al.. (2021). Honokiol Suppresses Perineural Invasion of Pancreatic Cancer by Inhibiting SMAD2/3 Signaling. Frontiers in Oncology. 11. 728583–728583. 27 indexed citations
12.
Zhang, Simei, Wunai Zhang, Ying Xiao, et al.. (2020). Targeting MUC15 Protein in Cancer: Molecular Mechanisms and Therapeutic Perspectives. Current Cancer Drug Targets. 20(9). 647–653. 9 indexed citations
13.
Wang, Zheng, Simei Zhang, Ying Xiao, et al.. (2020). NLRP3 Inflammasome and Inflammatory Diseases. Oxidative Medicine and Cellular Longevity. 2020. 1–11. 265 indexed citations breakdown →
14.
Zhang, Wunai, Rui He, Shuo Chen, et al.. (2020). The JAM-B/c-src/MMP9 pathway is associated with progression and regulates the invasion of pancreatic cancer. Journal of Cancer. 11(11). 3246–3255. 8 indexed citations
15.
He, Rui, Wunai Zhang, Shuo Chen, et al.. (2020). Transcriptional Profiling Reveals the Regulatory Role of DNER in Promoting Pancreatic Neuroendocrine Neoplasms. Frontiers in Genetics. 11. 587402–587402. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026